http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109596834-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2018-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109596834-B |
| titleOfInvention | Surfactant composition applied to in-vitro diagnostic reagent |
| abstract | The invention provides a surfactant composition applied to an in vitro diagnostic reagent, belonging to the technical field of surfactants, and comprising the following components: sucrose-glucose-6-carboxylic acid sodium-fructose-6-carboxylic acid sodium-1- (N-dodecyl formamide), sodium perfluorooctanoate, tetradecyl trimethyl ammonium bromide and Gemini surfactant 12-2-12, wherein the content of the sucrose-glucose-6-carboxylic acid sodium-fructose-6-carboxylic acid sodium-1- (N-dodecyl formamide) is 5-80mM, the content of the sodium perfluorooctanoate is 10-100mM, the content of the tetradecyl trimethyl ammonium bromide is 10-100mM, and the content of the Gemini surfactant 12-2-12 is 0.1-2 mM. The invention can optimize the reaction system of the in vitro diagnostic reagent kit, improve the performance indexes of the kit such as repeatability, batch difference, accuracy, stability and the like, and is beneficial to prolonging the effective period of the in vitro diagnostic reagent. |
| priorityDate | 2018-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.